David Rokach
Vermogen: 6 675 $ op 31-05-2026
Vermogen: 6 675 $ op 31-05-2026
Mr. David Rokach is a Chief Financial & Accounting Officer at BiomX, Inc. He is on the Board of Directors at Nukkleus, Inc. (New Jersey).
Mr. Rokach was previously employed as an Independent Director by T3 Defense, Inc. He received his undergraduate degree from The Hebrew University of Jerusalem.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,02% | 07-04-2026 | 15.000 ( 0,02% ) | 6 675 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOMX INC. | Financieel Directeur/CFO | 27-02-2026 |
Nukkleus, Inc. (New Jersey)
Nukkleus, Inc. (New Jersey) Financial ConglomeratesFinance Provides blockchain and digital financial services | Directeur/Bestuurslid | 01-01-2024 |
| Bedrijven | Functie | Einde |
|---|
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Nukkleus, Inc. (New Jersey)
Nukkleus, Inc. (New Jersey) Financial ConglomeratesFinance Provides blockchain and digital financial services | Finance |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BiomX, Inc.
BiomX, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau